Clinical trial
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating…
NCT00423293 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00423293 |
|---|---|
| Title | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer |
| Official title | A Phase II Evaluation of Dose-Painted Intensity-Modulated Radiation Therapy (IMRT) in Combination With 5-Fluorouracil (5-FU) and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | fluorouracil, mitomycin C, Intensity-modulated radiation therapy |
| Enrollment | 63 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Dec 1, 2016 |
| First posted | Jan 18, 2007 |
| Last update posted | Feb 27, 2019 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: